Cells in the liver with whole genome duplications, known as polyploid cells, can protect the liver against cancer, discovered a research team at the Children's Medical Center Research Institute (CRI) at UT Southwestern. The study, published in Developmental Cell, addresses a long-standing mystery in liver biology and could stimulate new ideas to prevent cancer.
Most human cells are diploid, carrying only one set of matched chromosomes that contain each person's genome. Polyploid cells carry two or more sets of chromosomes. Although rare in most human tissues, these cells are prevalent in the hearts, blood, and livers of mammals. Polyploidization also increases significantly when the liver is exposed to injury or stress from fatty liver disease or environmental toxins that could cause liver cancer later in life. It is unknown, however, whether these increases in polyploidization have functional importance.
New Way to Kill Liver Cancer
Silencing a key cellular enzyme and treating cells with a diabetes drug, a successful strategy for cancer therapy.
Advertisement
‘Liver cells with whole genome duplication protect against cancer formation in the liver and do not affect liver regeneration.’
Tweet it Now
Previous research into the exact function of polyploid liver cells has been limited, in part because it has been difficult to change the number of sets of chromosomes in a cell, or ploidy, without introducing permanent mutations in genes that may also affect other cellular activities, such as division, regeneration, or cancer development. Because of this, there were many ideas as to why the liver is polyploid, but little experimental evidence.
CRI researchers have discovered a new approach.
"Our lab has developed new methods to transiently and reversibly alter ploidy for the first time. This was an important advance because it allowed us to separate the effects of ploidy from the effects of genes that change ploidy. Using these techniques, we were able to show polyploid liver cells protected the liver against cancer formation in the mouse," said Dr. Hao Zhu, Assistant Professor at CRI and a CPRIT scholar in Cancer Research.
![Liver Cancer Mortality Rates Nearly Double Since the 1990s]( "Liver Cancer Mortality Rates Nearly Double Since the 1990s")
New figures reveal deaths from liver cancer nearly doubled since the 1990s.
Surprisingly, livers with more polyploid cells do not have problems regenerating after various injuries.
These findings challenge a long-held concept that polyploidy is generally a pro-cancer state. They suggest instead it could be an adaptive response within normal liver cells. In humans, cancer develops when genes that suppress cancer, known as tumor suppressors, are lost and when mutations or genes that promote cancer, known as oncogenes, are gained or activated.
"We found polyploidy in liver cells did not strongly affect the activity of some oncogenes, but it did protect against the loss of tumor suppressor genes. When normal diploid cells lose one or both copies of tumor suppressor genes, cancers can form. Polyploid cells, which carry additional copies of important tumor suppressor genes, are better protected and more resistant to cancer formation because they have these extra copies of the genome," said Dr. Zhu, who is also an Assistant Professor of Pediatrics and Internal Medicine at UT Southwestern.
Future work in the Zhu lab will focus on the role of polyploidy in a variety of chronic liver diseases that frequently lead to liver cancer.
Source: Eurekalert
"Our lab has developed new methods to transiently and reversibly alter ploidy for the first time. This was an important advance because it allowed us to separate the effects of ploidy from the effects of genes that change ploidy. Using these techniques, we were able to show polyploid liver cells protected the liver against cancer formation in the mouse," said Dr. Hao Zhu, Assistant Professor at CRI and a CPRIT scholar in Cancer Research.
Liver Cancer Mortality Rates Nearly Double Since the 1990s
New figures reveal deaths from liver cancer nearly doubled since the 1990s.
Advertisement
Surprisingly, livers with more polyploid cells do not have problems regenerating after various injuries.
These findings challenge a long-held concept that polyploidy is generally a pro-cancer state. They suggest instead it could be an adaptive response within normal liver cells. In humans, cancer develops when genes that suppress cancer, known as tumor suppressors, are lost and when mutations or genes that promote cancer, known as oncogenes, are gained or activated.
"We found polyploidy in liver cells did not strongly affect the activity of some oncogenes, but it did protect against the loss of tumor suppressor genes. When normal diploid cells lose one or both copies of tumor suppressor genes, cancers can form. Polyploid cells, which carry additional copies of important tumor suppressor genes, are better protected and more resistant to cancer formation because they have these extra copies of the genome," said Dr. Zhu, who is also an Assistant Professor of Pediatrics and Internal Medicine at UT Southwestern.
Future work in the Zhu lab will focus on the role of polyploidy in a variety of chronic liver diseases that frequently lead to liver cancer.
Source: Eurekalert
Blocking A Protein That Stimulates Fat Synthesis May Help Treat Liver Cancer
The accumulation of fatty acids and lipids in the liver is one of the major causes of hepatocellular carcinoma or liver cancer.
Advertisement
 Scientists Discover How to Switch Liver Cancer Cell GrowthThe liver cancer cell line is an important cell line for the pharmaceutical industry for testing anti-cancer drugs. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
